Healthcare -
Biotechnology - NASDAQ - US
$ 689.5
-3.99 %
$ 74.1 B
Market Cap
17.98
P/E
REGN - TOTAL LIABILITIES
Total Liabilities REGN - Regeneron Pharmaceuticals, Inc.
8.41 B
LAST VALUE
13.28%
2 YEAR CAGR
17.74%
5 YEAR CAGR
20.25%
10 YEAR CAGR